Cargando…
Network Pharmacology Analysis of ZiShenWan for Diabetic Nephropathy and Experimental Verification of Its Anti-Inflammatory Mechanism
BACKGROUND: Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). The inflammatory response plays a critical role in DN. ZiShenWan (ZSW) is a classical Chinese medicinal formula with remarkable clinical therapeutic effects on DN, but its pharmacological action mechanisms...
Autores principales: | Guo, Xiaoyuan, Wu, You, Zhang, Chengfei, Wu, Lili, Qin, Lingling, Liu, Tonghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055297/ https://www.ncbi.nlm.nih.gov/pubmed/33883881 http://dx.doi.org/10.2147/DDDT.S297683 |
Ejemplares similares
-
Zi Shen Wan Fang Attenuates Neuroinflammation and Cognitive Function Via Remodeling the Gut Microbiota in Diabetes-Induced Cognitive Impairment Mice
por: Shi, Jiangwei, et al.
Publicado: (2022) -
Network pharmacology approach and experimental verification of Dan-Shen Decoction in the treatment of ischemic heart disease
por: Gong, Difei, et al.
Publicado: (2022) -
Uncovering the Mechanisms of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation by Focused Network Pharmacology Approach
por: Huang, Tao, et al.
Publicado: (2018) -
The Protective Effect of Shen Qi Wan on Adenine-Induced Podocyte Injury
por: Lin, Yiyou, et al.
Publicado: (2020) -
A Chinese Patent Medicine JiaYanKangTai Alleviates Inflammatory Lesions of Experimental Autoimmune Thyroiditis by Regulating Interleukin-17 Signaling
por: Pan, Yajing, et al.
Publicado: (2022)